An immunohistochemical and molecular genetic study of 60 colorectal carcinoma brain metastases in pursuit of predictive biomarkers for cancer therapy
Authors:
- 24 January 2025
- journal article
- Published by Elsevier in Human Pathology
- Vol. 155, 105717
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
- Japan Agency for Medical Research and Development (JP23ama121008)
This publication has 51 references indexed in Scilit:
- Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 studyThe Lancet Oncology, 2022
- Wnt/β-catenin signaling in colorectal cancer: Is therapeutic targeting even possible?Biochimie, 2022
- Fragment-Based Discovery of MRTX1719, a Synthetic Lethal Inhibitor of the PRMT5•MTA Complex for the Treatment of MTAP-Deleted CancersJournal of Medicinal Chemistry, 2022
- Strategies to tackle RAS-mutated metastatic colorectal cancerESMO Open, 2021
- Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal CancerCancer Cell, 2018
- PD-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary morphology and cytotoxic tumor-infiltrating lymphocytesLaboratory Investigation, 2016
- Cathepsin B promotes colorectal tumorigenesis, cell invasion, and metastasisMolecular Carcinogenesis, 2015
- Progression-Free Survival Remains Poor Over Sequential Lines of Systemic Therapy in Patients With BRAF-Mutated Colorectal CancerClinical Colorectal Cancer, 2014
- B7‐H3 expression in colorectal cancer: Nuclear localization strongly predicts poor outcome in colon cancerInternational Journal of Cancer, 2012
- Oncogenic PIK3CA mutations in colorectal cancers and polypsInternational Journal of Cancer, 2011